Hesham ElGhazaly, Elected President of the Executive Board at Egyptian Cancer Society, Professor of Clinical Oncology at Ain Shams University, and the Founder and CEO of Alfa Cure Oncology Center, shared a post on LinkedIn:
“BGIICC, What Started Between Friends Now Unites Global Oncology!
Began 18 years ago as a nice conversation then an unusual collective effort among friends, driven by one shared purpose—to improve cancer care—has grown into The Breast Gynecological and Immunooncology International Cancer Conference-BGICC, a platform that today unites disciplines, institutions, and global leaders.
BGIICC was never meant to be just a conference it was built to bring people together, break the barriers, and turn collaboration into action.
Over time, that spirit of unity transformed into trusted space where science meets real world practice, a bridge between global evidence and regional needs and a meeting point for clinicians, researchers, policymakers, and partners.
This year, BGIICC evolves from a conference into a catalyst for change.
By aligning global scientific leadership with economic and policy dialogue.
With leading organizations such as World Health Organization, IARC – International Agency for Research on Cancer/World Health Organization, American Society of Clinical Oncology (ASCO), International Association for the Study of Lung Cancer, AORTIC- Africa, and ESMO – European Society for Medical Oncology contributing, the focus extends from breakthrough science to shaping guidelines, strengthening systems, and investing in the next generation of oncology leaders.
Stay tuned for more to be announced.”
More posts featuring Hesham ElGhazaly.
